STERIS plc (STE)

Currency in USD
235.51
+14.30(+6.46%)
Real-time Data·
STE Scorecard
Full Analysis
High shareholder yield
STE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
226.58237.56
52 wk Range
200.98252.79
Key Statistics
Prev. Close
221.21
Open
227.85
Day's Range
226.58-237.56
52 wk Range
200.98-252.79
Volume
558.7K
Average Volume (3m)
637.13K
1-Year Change
-7.51%
Book Value / Share
67.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
268.50
Upside
+14.01%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 14 consecutive years

STERIS plc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

STERIS plc Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

STERIS plc SWOT Analysis


Organic Growth Leade
STERIS demonstrates consistent organic revenue growth, maintaining a strong position in healthcare and pharmaceutical sectors despite market challenges
Valuation Premium
Explore STERIS's premium valuation compared to peers, reflecting its unique market position and growth potential in the large-cap MedTech group
Strategic Realignment
Learn about STERIS's recent divestiture of its Dental segment and its focus on core business areas, aimed at driving long-term growth and maintaining competitiveness
Analyst Optimism
Multiple analysts set a price target of $265 for STERIS, based on approximately 26-27 times the calendar year 2025 EPS estimate of $9.85
Read full SWOT analysis

STERIS plc Earnings Call Summary for Q4/2025

  • STERIS Q4 2025 EPS of $2.74 beat $2.60 forecast; revenue met expectations at $1.48B; stock rose 5.9% after-hours to $240.05
  • FY2025 free cash flow hit record $787M; full-year adjusted EPS $9.22; gross margin up 170bps to 44.3%; EBIT margin up 110bps to 24.8%
  • FY2026 guidance: 6-7% revenue growth, EPS $9.90-$10.15 (7-10% increase), EBIT margins to improve 20bps, effective tax rate 23.5%
  • Strategic focus on $20M restructuring savings, managing $30M tariff costs; CEO highlights resilience and capital equipment importance
  • Challenges include tariff impacts, bioprocessing volatility, healthcare capital equipment decline, and ongoing ETO litigation expenses
Last Updated: 15/05/2025, 14:44
Read Full Transcript

Compare STE to Peers and Sector

Metrics to compare
STE
Peers
Sector
Relationship
P/E Ratio
36.0x26.2x−0.5x
PEG Ratio
0.57−0.590.00
Price/Book
3.3x2.3x2.6x
Price / LTM Sales
4.2x1.8x3.3x
Upside (Analyst Target)
25.7%0.0%43.5%
Fair Value Upside
Unlock40.4%6.9%Unlock

Analyst Ratings

6 Buy
3 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 268.50
(+14.01% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.19%
Dividend Yield
1.14%
Industry Median 1.33%
Annualised payout
2.52
Paid quarterly
5-Years Growth
+8.99%
Growth Streak

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
2.34 / 2.26
Revenue / Forecast
1.39B / 1.36B
EPS Revisions
Last 90 days

STE Income Statement

People Also Watch

278.90
RMD
-0.56%
151.94
CAH
-2.98%
149.00
ZTS
+1.70%
186.43
BDX
+8.13%

FAQ

What Stock Exchange Does STERIS Trade On?

STERIS is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for STERIS?

The stock symbol for STERIS is "STE."

What Is the STERIS Market Cap?

As of today, STERIS market cap is 23.26B.

What Is STERIS's Earnings Per Share (TTM)?

The STERIS EPS (TTM) is 6.19.

When Is the Next STERIS Earnings Date?

STERIS will release its next earnings report on 09 Nov 2025.

From a Technical Analysis Perspective, Is STE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has STERIS Stock Split?

STERIS has split 2 times.

How Many Employees Does STERIS Have?

STERIS has 17787 employees.

What is the current trading status of STERIS (STE)?

As of 07 Aug 2025, STERIS (STE) is trading at a price of 235.51, with a previous close of 221.21. The stock has fluctuated within a day range of 226.58 to 237.56, while its 52-week range spans from 200.98 to 252.79.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.